In a preclinical study of mice bearing B7-H1/SCCVII tumors treated with adoptive T-cell transfer, anti-PD-1 therapy, or both, combination treatment was required to achieve ultimate tumor regression and prolonged animal survival [108]. Here, PDCD1 is linked to neoplasm.